(Q87972177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Masaki Ohya

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Takashi Shigematsu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

29 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

Clinical and experimental nephrology

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

835-836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

19 March 2020

cites work

1 reference

12 December 2020

Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy

1 reference

12 December 2020

Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without Hyperuricemia

1 reference

12 December 2020

Hyperuricemia is a significant risk factor for the onset of chronic kidney disease

1 reference

12 December 2020

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

12 December 2020

Uric acid: A marker of increased cardiovascular risk

1 reference

12 December 2020

Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.

1 reference

12 December 2020

Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease

1 reference

12 December 2020

Acute renal and hepatic failure associated with allopurinol treatment.

1 reference

12 December 2020

Association of serum uric acid with blood pressure in Japanese men. Cross-sectional study in work-site group

1 reference

12 December 2020

10.1007/S10157-014-0989-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24871070%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference